1198 results

Why are rare disease academic trials not the norm?

ERIC Forum Policy Report: Assessing the socio-economic impact of ERICS

A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines in adults ≥75 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED): a trial conducted within the VACCELERATE network

eCREAM

ECRIN staff summer school in Rome

ISIDORE INFORMATION WEBINAR

Joining forces to define the European Health Data Sharing Landscape for Research

EUPATI Fundamentals training

ECRIN Partners

Experience, Opportunities, and Challenges Implementing Personalised Medicine in Africa